- Record: found
- Abstract: not found
- Article: not found
A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)
JT Capdevila, C. Lopez, R García-Carbonero, M Benavent, A. Custodio, A. Cubillo, V. ALONSO, Gordoa Alonso, A. Carmona‐Bayonas, G Crespo, M. Blanco-Codesido, P Jimenez-Fonseca, A Viudez, Casta La, I Sevilla, M. LLANOS, A. SEGURA, J. Hernando-Cubero, JL Manzano, J CAPDEVILA, A Teulé, C. LOPEZ, TA Gordoa
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.